Latest news
May 24, 2017
Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen
May 9, 2017
BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development
March 23, 2017
Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study
March 10, 2017
Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case
March 7, 2017
Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
March 2, 2017
Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test
February 21, 2017
Debiopharm International SA Appeals to the Supreme Court regarding Nippon Kayaku Co., Ltd. case